Early Clinical Outcomes of the First Commercialized Human Autologous Ex Vivo Cultivated Oral Mucosal Epithelial Cell Transplantation for Limbal Stem Cell Deficiency: Two Case Reports and Literature Review.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
18 May 2023
Historique:
received: 30 04 2023
revised: 14 05 2023
accepted: 16 05 2023
medline: 29 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

The first product in the world for ex vivo cultivated oral mucosal epithelial cell transplantation (COMET) to treat limbal stem cell deficiency (LSCD), named Ocural

Identifiants

pubmed: 37240280
pii: ijms24108926
doi: 10.3390/ijms24108926
pmc: PMC10219018
pii:
doi:

Types de publication

Review Case Reports

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Promotion and Mutual Aid Corporation for Private Schools of Japan
ID : none

Références

Stem Cells Transl Med. 2018 Jan;7(1):146-154
pubmed: 29280318
Am J Ophthalmol. 2011 Aug;152(2):195-201.e1
pubmed: 21652025
Eye (Lond). 2011 Dec;25(12):1641-9
pubmed: 21941360
Cornea. 1999 Jan;18(1):52-8
pubmed: 9894937
Cornea. 2020 Oct;39(10):1291-1302
pubmed: 32639314
Cornea. 2018 Jan;37(1):76-83
pubmed: 29040119
Ophthalmology. 2023 Jun;130(6):608-614
pubmed: 36736434
Invest Ophthalmol Vis Sci. 2003 Jan;44(1):106-16
pubmed: 12506062
Invest Ophthalmol Vis Sci. 2012 Mar 21;53(3):1602-9
pubmed: 22323487
Ophthalmology. 1989 May;96(5):709-22; discussion 722-3
pubmed: 2748125
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3156-61
pubmed: 11248048
Stem Cells. 2007 Mar;25(3):628-38
pubmed: 17110619
Stem Cell Res Ther. 2021 Oct 7;12(1):524
pubmed: 34620226
J Pediatr Surg. 2009 Dec;44(12):2364-8
pubmed: 20006028
Curr Opin Ophthalmol. 2017 Jul;28(4):363-369
pubmed: 28426442
Am J Ophthalmol. 1963 Feb;55:302-12
pubmed: 13966160
Lancet. 1997 Apr 5;349(9057):990-3
pubmed: 9100626
Am J Ophthalmol. 2021 Feb;222:82-91
pubmed: 32818447
Arch Ophthalmol. 2008 Jan;126(1):23-8
pubmed: 18195214
Ocul Surf. 2017 Oct;15(4):789-794
pubmed: 28827194
Jpn J Ophthalmol. 2021 Mar;65(2):169-183
pubmed: 33591470
N Engl J Med. 2004 Sep 16;351(12):1187-96
pubmed: 15371576
Br J Ophthalmol. 2004 Oct;88(10):1280-4
pubmed: 15377551
Ophthalmology. 2011 Aug;118(8):1524-30
pubmed: 21571372
Stem Cell Res Ther. 2020 Jul 21;11(1):301
pubmed: 32693830
Ophthalmology. 2002 Jul;109(7):1278-84
pubmed: 12093650
Ophthalmology. 2007 Jun;114(6):1080-8
pubmed: 17275911
Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4660-8
pubmed: 19458337
Invest Ophthalmol Vis Sci. 2012 Aug 17;53(9):5615-23
pubmed: 22850415
Tissue Eng Part C Methods. 2014 May;20(5):373-82
pubmed: 24044382
Cell Tissue Bank. 2016 Sep;17(3):491-503
pubmed: 27507558
Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1359-67
pubmed: 16565369
Ophthalmology. 2013 Jan;120(1):193-200
pubmed: 23084239
Am J Ophthalmol. 2006 Nov;142(5):757-64
pubmed: 16989763
Biomed Res Int. 2015;2015:281870
pubmed: 26451366
J Cell Mol Med. 2008 Dec;12(6B):2799-811
pubmed: 19210757
Eye (Lond). 2009 Jun;23(6):1442-50
pubmed: 19373264
Am J Ophthalmol. 2006 Feb;141(2):267-275
pubmed: 16458679
Sci Rep. 2016 Nov 14;6:37173
pubmed: 27841343
Graefes Arch Clin Exp Ophthalmol. 2019 Jun;257(6):1253-1263
pubmed: 31004182
J Med Case Rep. 2022 Aug 4;16(1):298
pubmed: 35922868
Cornea. 1994 Sep;13(5):389-400
pubmed: 7995060
In Vitro Cell Dev Biol Anim. 2010 Oct;46(9):774-80
pubmed: 20844981
Stem Cells. 2014 Aug;32(8):2135-46
pubmed: 24590515
Invest Ophthalmol Vis Sci. 2012 Mar 13;53(3):1325-31
pubmed: 22064987
N Engl J Med. 1999 Jun 3;340(22):1697-703
pubmed: 10352161
Acta Ophthalmol. 2014 Sep;92(6):e447-53
pubmed: 24835597
Cornea. 2021 Jul 1;40(7):842-850
pubmed: 33079916
Arch Ophthalmol. 2006 Nov;124(11):1543-51
pubmed: 17102000
Transplantation. 2004 Feb 15;77(3):379-85
pubmed: 14966411
Br J Ophthalmol. 2011 Jul;95(7):942-6
pubmed: 21097786
Arch Ophthalmol. 1986 Oct;104(10):1529-33
pubmed: 3767686
Cornea. 2019 Mar;38(3):364-375
pubmed: 30614902

Auteurs

Hiroshi Toshida (H)

Department of Ophthalmology, Juntendo University Shizuoka Hospital, Shizuoka 410-2211, Japan.

Tomoto Kasahara (T)

Department of Ophthalmology, Juntendo University Shizuoka Hospital, Shizuoka 410-2211, Japan.

Masamichi Kiriyama (M)

Department of Ophthalmology, Juntendo University Shizuoka Hospital, Shizuoka 410-2211, Japan.

Yuma Iwasaki (Y)

Department of Ophthalmology, Juntendo University Shizuoka Hospital, Shizuoka 410-2211, Japan.

Jobu Sugita (J)

Department of Ophthalmology, Juntendo University Shizuoka Hospital, Shizuoka 410-2211, Japan.

Kohei Ichikawa (K)

Department of Ophthalmology, Juntendo University Shizuoka Hospital, Shizuoka 410-2211, Japan.

Toshihiko Ohta (T)

Department of Ophthalmology, Juntendo University Shizuoka Hospital, Shizuoka 410-2211, Japan.

Katsumi Miyahara (K)

Laboratory of Morphology and Image Analysis, Biomedical Research Core Facilities, Juntendo University Graduate School of Medicine, Tokyo 113-0033, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH